Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hercules Technology Growth Capital (HTGC)

Hercules Technology Growth Capital (HTGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,989,261
  • Shares Outstanding, K 181,718
  • Annual Sales, $ 493,590 K
  • Annual Income, $ 262,970 K
  • EBIT $ 322 M
  • EBITDA $ 330 M
  • 60-Month Beta 0.84
  • Price/Sales 7.36
  • Price/Cash Flow 7.96
  • Price/Book 1.36

Options Overview Details

View History
  • Implied Volatility 38.71% (+1.84%)
  • Historical Volatility 23.86%
  • IV Percentile 98%
  • IV Rank 68.42%
  • IV High 49.67% on 04/08/25
  • IV Low 14.95% on 08/29/25
  • Expected Move (DTE 12) 1.11 (6.72%)
  • Put/Call Vol Ratio 0.90
  • Today's Volume 1,531
  • Volume Avg (30-Day) 2,048
  • Put/Call OI Ratio 2.47
  • Today's Open Interest 39,096
  • Open Int (30-Day) 28,599
  • Expected Range 15.35 to 17.56

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.48
  • Number of Estimates 2
  • High Estimate 0.48
  • Low Estimate 0.48
  • Prior Year 0.49
  • Growth Rate Est. (year over year) -2.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.22 +1.42%
on 02/05/26
19.00 -13.40%
on 01/15/26
-2.16 (-11.61%)
since 01/06/26
3-Month
16.22 +1.42%
on 02/05/26
19.13 -14.01%
on 12/05/25
-1.33 (-7.48%)
since 11/06/25
52-Week
15.65 +5.11%
on 04/09/25
22.04 -25.36%
on 02/19/25
-4.38 (-21.03%)
since 02/06/25

Most Recent Stories

More News
Hercules Capital Prices Institutional Notes Offering of $300.0 Million 5.350% Notes due 2029

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” “Hercules Capital,” or the “Company”), today announced that it has priced an underwritten public offering of $300.0 million in aggregate...

HTGC : 16.45 (+0.73%)
HCXY : 25.19 (+0.20%)
Affirm, Nubank, Enova, Hercules Capital, and Interactive Brokers Shares Are Soaring and Falling, What You Need To Know

Affirm, Nubank, Enova, Hercules Capital, and Interactive Brokers Shares Are Soaring and Falling, What You Need To Know

IBKR : 74.59 (+7.34%)
ENVA : 161.10 (+0.83%)
NU : 17.40 (+3.51%)
HTGC : 16.45 (+0.73%)
AFRM : 57.03 (-4.02%)
Hercules Capital (HTGC): Buy, Sell, or Hold Post Q3 Earnings?

Hercules Capital (HTGC): Buy, Sell, or Hold Post Q3 Earnings?

HTGC : 16.45 (+0.73%)
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2025 Financial Results and Conference Call

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established...

HTGC : 16.45 (+0.73%)
HCXY : 25.19 (+0.20%)
3 Low-Volatility Stocks We Find Risky

3 Low-Volatility Stocks We Find Risky

BCC : 91.03 (+2.10%)
HTGC : 16.45 (+0.73%)
HG : 29.70 (+0.78%)
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*

-- When Combined with Recently Announced $75M Royalty Financing, the Company Will Have Access to ~$150M of Non-Dilutive Capital for Launch of MOLBREEVI --

SVRA : 5.30 (+2.71%)
HTGC : 16.45 (+0.73%)
2 Financials Stocks for Long-Term Investors and 1 We Turn Down

2 Financials Stocks for Long-Term Investors and 1 We Turn Down

LAZ : 56.80 (+4.30%)
MC : 73.25 (+2.19%)
HTGC : 16.45 (+0.73%)
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.

Up to $100 million in additional loan proceeds provide additional financial flexibility to advance detalimogene development and commercialization for bladder cancer $25...

ENGN : 9.55 (+7.79%)
HTGC : 16.45 (+0.73%)
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial ...

CMPS : 6.19 (+8.41%)
HTGC : 16.45 (+0.73%)
3 Value Stocks That Concern Us

3 Value Stocks That Concern Us

GTM : 7.31 (+7.82%)
CROX : 85.81 (+1.56%)
HTGC : 16.45 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading...

See More

Key Turning Points

3rd Resistance Point 16.86
2nd Resistance Point 16.72
1st Resistance Point 16.59
Last Price 16.45
1st Support Level 16.32
2nd Support Level 16.18
3rd Support Level 16.05

See More

52-Week High 22.04
Fibonacci 61.8% 19.60
Fibonacci 50% 18.85
Fibonacci 38.2% 18.09
Last Price 16.45
52-Week Low 15.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar